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Abstract
Prolyl 3-hydroxylase 1 (P3H1), encoded by the LEPRE1 gene, forms a molecular complex with cartilage-associated protein
(CRTAP) and cyclophilin B (encoded by PPIB) in the endoplasmic reticulum (ER). This complex is responsible for one step in
collagen post-translational modification, the prolyl 3-hydroxylation of specific proline residues, specifically a1(I) Pro986.
P3H1 provides the enzymatic activity of the complex and has a Lys-Asp-Glu-Leu (KDEL) ER-retrieval sequence at the carboxyl
terminus. Loss of function mutations in LEPRE1 lead to the Pro986 residue remaining unmodified and lead to slow folding
and excessive helical post-translational modification of type I collagen, which is seen in both dominant and recessive
osteogenesis imperfecta (OI). Here, we present the case of siblings with non-lethal OI due to novel compound heterozygous
mutations in LEPRE1 (c.484delG and c.2155dupC). The results of RNA analysis and real-time PCR suggest that mRNA with
c.2155dupC escapes from nonsense-mediated RNA decay. Without the KDEL ER- retrieval sequence, the product of the
c.2155dupC variant cannot be retained in the ER. This is the first report of a mutation in LEPRE1 that eliminates only the
KDEL ER-retrieval sequence, whereas other functional domains remain intact. Our study shows, for the first time, that the
KDEL ER- retrieval sequence is essential for P3H1 functionality and that a defect in KDEL is sufficient for disease onset.
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Introduction
Osteogenesis imperfecta (OI; MIM #166200, #166210,
#259420, #166220, #610967, #610968, #610682, #610915,
#259440, #613848 and #613982) comprises a heterogeneous
group of connective tissue disorders characterized by fragile bones
with susceptibility to fractures. Most cases of OI are caused by
heterozygous mutations in COL1A1 or COL1A2, the genes
encoding the two type I procollagen alpha chains, proa1 (I) and
proa2 (I) [1]. Mutations in these genes result in quantitative and/
or qualitative defects in type I collagen production by osteoblasts
[2–4].
Recurrence of severe OI in families with unaffected parents
results from either dominant (parental mosaicism) or recessive
inheritance [5–7]. Recent investigations have discovered several
genes responsible for OI inherited as an autosomal recessive trait
[8–18]. Among these genes, LEPRE1 encodes prolyl 3-hydroxylase
1 (P3H1), which forms a molecular complex with cartilage-
associated protein (CRTAP) and cyclophilin B (CypB, encoded by
PPIB) in the endoplasmic reticulum (ER) that is responsible for one
step in collagen post-translational modification, the prolyl 3-
hydroxylation of specific proline residues, specifically a1(I) Pro986
[19]. P3H1 provides the enzymatic activity of the complex and is
the only component of the complex with a Lys-Asp-Glu-Leu
(KDEL) ER-retrieval sequence at the carboxyl terminus [20]. Loss
of function mutations in either LEPRE1 or CRTAP lead to loss of
both proteins in the cell, leave the Pro986 residue unmodified, and
lead to slow folding and excessive helical post-translational
modification of type I collagen [21].
To date, more than 20 LEPRE1 mutations have been described
[10,21–25]. With the exception of only one missense mutation,
Leu489Pro [25], all LEPRE1 mutations result in a premature
termination codon (PTC) with mRNA that is destroyed by the
process of nonsense-mediated RNA decay. Here we present the
case of siblings with OI due to novel compound heterozygous
mutations in LEPRE1 (c.484delG and c.2155dupC). Without the
KDEL ER- retrieval sequence, the product of the c.2155dupC
variant cannot be retained in the ER. Our study shows, for the first
time, that the KDEL ER- retrieval sequence is essential for P3H1
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36809functionality and that a defect in KDEL is sufficient for disease
onset.
Results
Patient Reports
Patient II-2 was a 5-year-old female born to healthy parents
who already had one healthy child (Fig 1A). Prenatal ultrasonog-
raphy at 28 weeks of gestation showed deformity of the lower
limbs. She was delivered with multiple fractures by caesarian
section at 35 weeks’ gestation. Birth weight was 1966 g (below 3
rd
percentile), length 42.2 cm (below 3
rd percentile), and OFC
31.2 cm (3
rd–10
th percentile). She did not have blue sclera or
dysmorphic facial features, such as micrognathia or a triangular
face. She had no neonatal respiratory distress. Radiographs
showed multiple rib fractures, healed fractures of both femora and
the right humerus, and a subacute fracture of the left humerus
(Fig 1B). Metaphyseal osteopenia was significant. A diagnosis of
OI type III was made. At least 10 fractures occurred in the first 6
months of life. Pamidronate treatment was initiated at 2 months of
age. The pamidronate was initially administered by infusion every
2 months and was changed to every 3 months at the age of 2 years.
The bone mineral density (BMD) of the lumber spine (L2–L4) was
0.336 gm/cm
2 (Z score of –2.2), 0.429 g/cm
2 (Z score of –2.7),
0.479 g/cm
2 (Z score of –4.9), and 0.514 g/cm
2 (Z score of –5.9)
at the ages of 1 year, 2 years, 4 years, and 5 years respectively (We
used BMD reference data [26] in Spanish children). She did not
have severe deformity of the long bones at age 5 years, and her
skin was normal in extensibility. She had white sclerae and normal
dentition. She was able to walk with difficulty while holding on to
a table. Her intellectual development was normal.
Patient II-3 was the product of couple’s next pregnancy; this
pregnancy was electively terminated. Postmortem radiographs
showed bilateral femoral bowing, a healed fracture of the right
femoral shaft, thin ribs, and metaphyseal demineralization
(Fig 1C).
Patient II-3 Bone Histology
Bone samples, obtained at autopsy, from Patient II-3 were
processed according to standard procedure, and the formalin fixed
paraffin-embedded sections were stained with hematoxylin and
eosin. Irregular trabeculae of woven bone rimed by osteoblasts
were observed in the humerus (Fig 1D) and spine (Fig 1E). The
stroma surrounding the woven bone was mildly to moderately
cellular and consisted of fibroblasts and collagen. These histolog-
ical features resembled those of osteofibrous dysplasia.
Detection of LEPRE1 Mutations
Sequence analysis revealed novel compound heterozygous
LEPRE1 mutations (c.484delG, p.A162LfsX22 and c.2155dupC,
p.E719RfsX11) in both patients (Fig 2A). Their father carried
c.484delG and their mother carried c.2155dupC. These mutations
were not found in 200 control alleles. No sequence variation was
found in COL1A1, COL1A2, CRTAP,o rPPIB, and neither exon-
level deletion nor duplication involving COL1A1 and COL1A2 was
detected by MLPA analysis. The p.E719RfsX11 mutation creates
a PTC in the last exon and results in the lack of only the KDEL
ER-retrieval sequence, whereas other functional domains, such as
the tetratricopeptide domain and Prolyl/Lysyl hydroxylase
domain, remain intact (Fig 2B).
LEPRE1 Transcripts and P3H1 Protein in Probands
Only the allele with c.2155 dupC was successfully amplified and
sequenced at the cDNA level.
Real-Time PCR revealed that the level of LEPRE1 transcripts of
Patient II-3 was about one-half the control level (Fig 3A).
Western blot analysis of fibroblast lysates confirmed the absence
of intracellular P3H1 in Patient II-3 (Fig 3C). Fluorescent
microscopy showed the expected colocalization of P3H1 and
CRTAP with GRP94 in control cells. Both P3H1 and CRTAP
proteins were absent in fibroblasts from Patient II-3 (Fig 3D),
reflecting mutual protection in the complex.
Collagen Post-translational Modification
In both the cell layer and media, steady-state fibroblast collagen
of Patient II-3 displayed helical overmodification, detected as
back-streaking of collagen alpha chain bands on gel electropho-
resis (Fig 3B).
Tandem mass spectrometry analysis of tryptic peptides of
Patient II-3 secreted a1 (I)-collagen chains revealed only a slight
reduction (85% in proband, 95–98% in control collagen) of
Pro986 3-hydroxylation (data not shown) despite the absence of
detectable mutant P3H1 protein in the cell.
Discussion
ER-resident proteins must be distinguished from newly synthe-
sized secretory proteins, which pass through this compartment as
they transit the secretory pathway toward the extracellular space.
One of the mechanisms by which this is achieved is the selective
retrograde transport of soluble ER-resident proteins from the cis-
Golgi to the ER [27]. Receptors in post-ER compartments
recognize a C-terminal motif that marks proteins that are to be
retained in the ER. The KDEL motif binds to this salvaging
receptor (KDEL receptor) in the Golgi, resulting in this ligand-
receptor complex being returned to the ER [27]. Soluble ER-
resident proteins such as molecular chaperones and components of
the control quality machinery, e.g. immunoglobulin heavy-chain
binding protein, calreticulin, and protein disulfide isomerase,
contain the KDEL motif at the carboxyl terminus. P3H1, encoded
by LEPRE1, forms a molecular complex with CRTAP and CypB
in the ER, and provides the enzymatic activity of the complex.
P3H1 is the only component of the complex with a KDEL ER-
retrieval sequence at the carboxyl terminus [20]. One splice
mutation, c.2055+18G.A, which abolishes the LEPRE1 mRNA
splice form of KDEL, has previously been reported [23]. This
splice mutation results in preferential use of alternative splice
donor site, and a significant decrease in the LEPRE1 mRNA splice
form containing the KDEL sequence. However, this finding does
not provide direct evidence for the importance of the KDEL
sequence. The case presented here is therefore the first report of
a mutation in LEPRE1 that eliminates only the KDEL ER-
retrieval sequence, while all other functional domains remain
intact. Without the KDEL ER- retrieval sequence, the
c.2155dupC variant will not captured by KDEL receptor in the
Golgi. Our report shows, for the first time, that the KDEL ER-
retrieval sequence is essential for P3H1 functionality in vivo.
Dysfunction of this KDEL-KDEL receptor interaction will
provide us one disease causing mechanism of OI as well as other
diseases involved in ER enzyme.
It is noteworthy that our proband’s collagen contained higher
percentage (85%) of 3-hydroxylated Pro986 residues than pre-
viously reported with LEPRE1 null mutations, which showed
severely reduced (0–15%) 3-hydroxylation of Pro986 [10,22,23].
We could not detect mutant P3H1 in the proband cells by western
blotting assay or fluorescent microscopy. However, we hypothesize
that the P3H1/CRTAP/CyPB complex that includes the mutant
P3H1 without KDEL must be transiently present in the ER at
KDEL Sequence Is Essential for P3H1
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a1(I) Pro986 residues. Recently, it was reported that the P3H1/
CRTAP/CyPB complex has 3 distinct activities: it is a prolyl 3-
hydroxylase, a PPIase, and a molecular chaperone [28]. In the
present patient, despite the higher percentage of 3-hydroxylated
Pro986 residues, overmodification of the patient’s type I collagen
was observed electrophoretically. This observation implicates the
dysfunctional P3H1/CRTAP/CyPB complex in the pathology,
with potential roles for absence of its chaperone or PPIase
functions. However, since our proband has generally milder OI
than described for null LEPRE1 mutations, the OI severity may
correlate with the level of type I collagen P986 3-hydroxylation.
In conclusion, our study shows, for the first time, that the KDEL
ER- retrieval sequence is important for P3H1 functionality in vivo.
In addition, the higher percentage of 3-hydroxylated P986
residues seen in the collagen of our patient correlates with her
moderate phenotype, in contrast to the severe/lethal OI of
probands with null LEPRE1 mutations and minimal collagen 3-
hydroxylation.
Materials and Methods
PCR-Based Mutation Screening
Approval for this study was obtained from the Institutional
Review Board of Keio University School of Medicine. The parents
gave written informed consent for the molecular studies.
Genomic DNA was extracted from peripheral blood (Patient II-
2) and blood of the umbilical cord (Patient II-3) by a standard
technique. We analyzed all coding exons and flanking introns of
COL1A1, COL1A2, LEPRE1, CRTAP, and PPIB by PCR and direct
sequencing. Deletion or duplication involving COL1A1 and
COL1A2 was checked by multiplex ligation-dependent probe
amplification (MLPA) analyses (SALSA MLPA KIT P271, P272;
MRC-Holland, Amsterdam, The Netherlands).
Figure 1. Features of Siblings with Mutations of LEPRE1. A: The pedigree of the affected family. The arrow indicates the proband. Patient II-3
was electively terminated. B: Radiographs of Patient II-2 as a neonate. There were multiple rib fractures, healed fractures of both femora and the right
humerus, and a subacute fracture of the left humerus. Metaphyseal osteopenia was significant. C: Postmortem radiographs of Patient II-3. Bilateral
femoral bowing, a healed fracture of the right femoral shaft, thin ribs, and metaphyseal demineralization were shown. D, E: Histological findings of
Patient II-3. Irregular trabeculae of woven bones lined by osteoblasts are observed in the humerus (D) and spine (E). The stroma is cellular and
consists of fibroblasts and collagen resembling osteofibrous dysplasia.
doi:10.1371/journal.pone.0036809.g001
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Total RNA was extracted from skin fibroblasts of Patient II-3
and cDNA synthesis was performed with the SuperScript III
reverse transcriptase kit (Invitrogen, Carlsbad, CA) with oligoDT
primers. Exons 2 and 15 of LEPRE1 were amplified from cDNA
by PCR. Subsequently, the PCR products were subjected to direct
sequencing.
Real-time quantitative PCR was performed on the ABI PRISM
7500 Fast Real-Time PCR System (Applied Biosystems, Foster
City, CA). For PCR reaction, we used SYBR Premix Ex Taq II
Figure 2. Identification of LEPRE1 mutations. A: A partial sequence of PCR product of Patient II-3 is shown. Compound heterozygous frame shift
mutations (c.484delG, p.A162LfsX22 and c.2155dupC, p.E719RfsX11) are indicated by arrows. The mutations have been confirmed by the subsequent
sequencing of subcloned products of normal and mutant alleles. B: Schematic presentation of the positions of the mutation. LEPRE1 cDNA encodes
the tetratricopeptide repeat domain (four black regions), the Prolyl/Lysyl/hydroxylase domain (green region), and the KDEL ER- retrieval motif (red
region). LEPRE1 with a p.E719RfsX11 change results in the lack of only the KDEL ER-retrieval sequence, whereas other functional domains remain
intact.
doi:10.1371/journal.pone.0036809.g002
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level, by real-time RT-PCR. B: Steady-state type I collagen protein from fibroblasts of Patient II-3 and a normal control is shown. In both the cell layer
and media, overmodification, detected as back-streaking of collagen alpha chains (a1 (I) and a2 (I)) on gel electrophoresis, is present in Patient II-3.
We also detected mild overmodification of type V collagen (a1 (V)). C: Western blots of fibroblast P3H1 in Patient II-3 and control cells confirm
absence of intracellular P3H1. D: Immunofluorescent staining of fibroblasts from Patient II-3 and a normal control show colocalization of P3H1 and
CRTAP with GRP94 in control cells. Both P3H1 and CRTAP proteins are absent in fibroblasts from Patient II-3.
doi:10.1371/journal.pone.0036809.g003
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a control fibroblast mRNA standard curve, then normalized to
a constitutively expressed gene (b2-microglobulin). All reactions
were carried out in triplicate and expression levels were de-
termined in 3 independent experiments.
Western Blotting
Skin fibroblasts from Patient II-3 and a control subject were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) and
were lysed in RIPA buffer (Sigma). Samples were subjected to 10%
SDS-PAGE and then transferred onto polyvinylidene fluoride
membrane. The membrane was treated with 10% milk powder
solution overnight at 4uC, and incubated with primary antibody:
mouse anti-LEPRE1 MaxPab polyclonal antibody (Abnova,
Taipei, Taiwan) at a 1:1000 dilution. After washing, the
membrane was incubated with secondary antibody: goat anti-
mouse HRP conjugated (Invitrogen) at a 1:1000 dilution. The
membrane was washed again and then scanned to visualize the
specific protein band.
Steady-state Collagen Analysis
Control and Patient II-3 dermal fibroblasts were grown to
confluence in DMEM + Glutamax
TM supplemented with 10%
fetal bovine serum and penicillin/streptomycin. Cells were labeled
overnight in serum-free medium containing 50 mg/ml ascorbic
acid and 437.5 mCi/ml L-[2,3,4,5-
3H]proline. Collagens were
precipitated with ammonium sulfate, pepsin-digested and separat-
ed on 6% SDS-Urea PAGE.
Immunocytochemistry
Immunofluorescence microscopy was performed as described
[21]. Control and Patient II-3 dermal fibroblasts were grown on
chamber slides. For CRTAP/GRP94 staining, cells were fixed in
4% paraformaldehyde, permeabilized with 0.1% TritonX-100 on
ice, and blocked in 1% BSA in PBS. Cells were then incubated
overnight with primary antibody (CRTAP, Abnova, Taipei,
Taiwan; GRP94, Abcam, Cambridge, MA). After washing, cells
were incubated with 1:200 Alexa Fluor secondary antibodies
(Invitrogen) in blocking buffer for 1 h, washed, and mounted with
coverslips. Cells were imaged using a Zeiss LSM 510 Inverted
Meta microscope and LSM510 software. P3H1/GRP94 staining
was done following the protocol of Willaert et al [23]. Cells were
washed, then fixed and permeabilized in cold acetone. Cells were
then blocked in 10% goat serum and incubated with primary
antibody (LEPRE1 MaxPab, Abnova, Taipei, Taiwan) for 2.5 h.
Secondary staining and imaging was done as above.
Tandem Mass Spectrometry
Secreted collagens from ascorbic acid stimulated fibroblast
cultures were precipitated and the a1(I) bands were isolated and
digested with trypsin. Electrospray mass spectrometry was
performed as before [9].
Acknowledgments
We thank the patients and their families for participation in this study. We
also thank Prof. Takao Takahashi for fruitful discussion. We would like to
acknowledge the NICHD Microscopy and Imaging Core, in which the
confocal microscopy was conducted.
Author Contributions
Conceived and designed the experiments: M. Takagi DRE JCM TH.
Performed the experiments: M. Takagi AMB MW. Analyzed the data: M.
Takagi AMB MW RF GN. Contributed reagents/materials/analysis tools:
TI NA M. Tanaka. Wrote the paper: M. Takagi JCM TH.
References
1. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, et al. (2007)
Consortium for osteogenesis imperfect mutations in the helical domain of type I
collagen: regions rich in lethal mutations align with collagen binding sites for
integrins and proteoglycans. Hum Mutat 28: 209–221.
2. Willing MC, Deschenes SP, Slayton RL, Roberts EJ (1996) Premature chain
termination is a unifying mechanism for COL1A1 null alleles in osteogenesis
imperfecta type I cell strains. Am J Hum Genet 59: 799–809.
3. Ko ¨rkko ¨ J, Ala-Kokko L, De Paepe A, Nuytinck L, Earley J, et al. (1998) Analysis
of the COL1A1 and COL1A2 genes by PCR amplification and scanning by
conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in
15 patients with osteogenesis imperfecta type I: identification of common
sequences of null-allele mutations. Am J Hum Genet 62: 98–110.
4. Forlino A, Cabral WA, Barnes AM, Marini JC (2011) New perspectives on
osteogenesis imperfecta. Nat Rev Endocrinol 7: 540–557.
5. Thompson EM, Young ID, Hall CM, Pembrey ME (1987) Recurrence risks and
prognosis in severe sporadic osteogenesis imperfecta. J Med Genet 24: 390–405.
6. Cohn DH, Starman BJ, Blumberg B, Byers PH (1990) Recurrence of lethal
osteogenesis imperfecta due to parental mosaicism for a dominant mutation in
a human type I collagen gene (COL1A1). Am J Hum Genet 46: 591–601.
7. Cohen-Solal L, Bonaventure J, Maroteaux P (1991) Dominant mutations in
familial lethal and severe osteogenesis imperfecta. Hum Genet 87: 297–301.
8. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, et al. (2006) CRTAP is
required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis
imperfecta. Cell 127: 291–304.
9. Barnes AM, Chang W, Morello R, Cabral WA, Weis M, et al. (2006) Deficiency
of cartilageassociated protein in recessive lethal osteogenesis imperfecta.
N Engl J Med 355: 2757–2764.
10. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, et al. (2007) Prolyl 3-
hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling
lethal/severe osteogenesis imperfecta. Nat Genet 39: 359–365.
11. van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR, et al. (2009)
PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 85:
521–527.
12. Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, et al. (2010) Lack of
cyclophilin B in osteogenesis imperfecta with normal collagen folding.
N Engl J Med 362: 521–528.
13. Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, et al. (2010)
Homozygosity for a missense mutation in SERPINH1, which encodes the
collagen chaperone protein HSP47, results in severe recessive osteogenesis
imperfecta. Am J Hum Genet 86: 389–398.
14. Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, et al. (2010)
Mutations in the gene encoding the RER protein FKBP65 cause autosomal-
recessive osteogenesis imperfecta. Am J Hum Genet 86: 551–559.
15. Lapunzina P, Aglan M, Temtamy S, Caparro ´s-Martı ´n JA, Valencia M, et al.
(2010) Identification of a frameshift mutation in Osterix in a patient with
recessive osteogenesis imperfecta. Am J Hum Genet 87: 110–114.
16. Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, et al. (2011) Exome sequencing
identifies truncating mutations in human SERPINF1 in autosomal-recessive
osteogenesis imperfecta. Am J Hum Genet 88: 362–371.
17. van Dijk FS, Byers PH, Dalgleish R, Malfait F, Maugeri A, et al. (2011) EMQN
best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta.
Eur J Hum Genet 20: 11–19.
18. Pyott SM, Schwarze U, Christiansen HE, Pepin MG, Leistritz DF, et al. (2011)
Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and
result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Hum
Mol Genet 20: 1595–1609.
19. Marini JC, Cabral WA, Barnes AM, Chang W (2007) Components of the
collagen prolyl 3- hydroxylation complex are crucial for normal bone
development. Cell Cycle 6: 1675–1681.
20. Vranka JA, Sakai LY, Ba ¨chinger HP (2004) Prolyl 3-hydroxylase 1, enzyme
characterization and identification of a novel family of enzymes. J Biol Chem
279: 23615–23621.
21. Chang W, Barnes AM, Cabral WA, Bodurtha JN, Marini JC (2010) Prolyl 3-
hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic
reticulum collagen prolyl 3-hydroxylation complex. Hum Mol Genet 19:
223–234.
22. Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, et al. (2008)
CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum
Mutat 29: 1435–1442.
23. Willaert A, Malfait F, Symoens S, Gevaert K, Kayserili H, et al. (2009) Recessive
osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation
and identification of the splice form responsible for prolyl 3-hydroxylation. J Med
Genet 46: 233–241.
KDEL Sequence Is Essential for P3H1
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e3680924. van Dijk FS, Nikkels PG, den Hollander NS, Nesbitt IM, van Rijn RR, et al.
(2011) Lethal/severe osteogenesis imperfecta in a large family: a novel
homozygous LEPRE1 mutation and bone histological findings. Pediatr Dev
Pathol 14: 228–34.
25. Zhang ZL, Zhang H, Ke YH, Yue H, Xiao WJ, et al. (2011) The identification
of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients
with osteogenesis imperfecta. J Bone Miner Metab (in press).
26. del Rio L, Carrascosa A, Pons F, Gusinye ´ M, Yeste D, et al. (1994) Bone mineral
density of the lumbar spine in white Mediterranean Spanish children and
adolescents: changes related to age, sex, and puberty. Pediatr Res 35: 362–366.
27. So ¨nnichsen B, Fu ¨llekrug J, Nguyen VP, Diekmann W, Robinson DG, et al.
(1994) Retention and retrieval: both mechanisms cooperate to maintain
calreticulin in the endoplasmic reticulum. J Cell Sci 107: 2705–2717.
28. Ishikawa Y, Wirz J, Vranka J, Nagata K, Ba ¨chinger H (2009) Biochemical
characterization of the prolyl 3-hydroxylase 1?cartilage-associated protein?cy-
clophilin B complex. J Biol Chem 284: 17641–17647.
KDEL Sequence Is Essential for P3H1
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36809